Albert David Faces Evaluation Shift Amid Declining Sales and Profit Challenges
Albert David, a microcap in the Pharmaceuticals & Drugs sector, has experienced a change in its evaluation, indicating a shift in market sentiment. The company faces challenges with declining net sales and contracting operating profit, yet maintains a low debt-to-equity ratio and a competitive return on equity.
Albert David, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an adjustment in evaluation, reflecting a shift in its technical outlook. The stock's technical indicators have shown a transition from a bearish stance to a mildly bearish position, suggesting a nuanced change in market sentiment.Key financial metrics reveal that Albert David has faced challenges in its recent performance. The company reported a significant decline in net sales, with the latest quarter reflecting the lowest figures in recent history. Additionally, the operating profit has contracted at an annual rate over the past five years, indicating ongoing struggles in maintaining growth.
Despite these hurdles, Albert David maintains a low debt-to-equity ratio, which may provide some stability. The company's return on equity stands at 10.6, and its price-to-book value is relatively attractive compared to industry peers. However, the stock has underperformed against broader market indices over various time frames, including a notable decline in returns over the past year.
As the evaluation adjustment unfolds, stakeholders will be keen to monitor how these underlying trends impact Albert David's market position moving forward.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
